
Patrick Soon-Shiong/immunitybio.com
Aug 12, 2025, 19:07
Patrick Soon-Shiong: Promising NK Cell and Bioshield Breakthrough for Waldenstrom’s
Patrick Soon-Shiong, Chairman of Chan Soon-Shiong Family Foundation, Executive Chairman at ImmunityBio, and Executive Chairman of the Los Angeles Times, shared a post on X:
“Waldenstrom’s, a rare form of lymphoma, where tumor cells can take over 90 percent of the bone marrow – patients at this stage of disease, when all treatment fails, are at life-threatening danger. News on the power of NK cells and Bioshield platform to the rescue coming soon.”
More posts featuring Pat Soon-Shiong.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Aug 13, 2025, 11:53
Aug 13, 2025, 11:24
Aug 13, 2025, 09:58
Aug 13, 2025, 09:33